Besides cancer treatment, VEGF/VEGFR inhibitors, including antibody fragments, aptamers, and VEGF-Traps were also approved and used for the treatment of ocular diseases caused by pathological angiogenesis [4,5,6,7,8]. This evidence concerns the gene KDR and cancer.